Eagle Pharmaceuticals Stock Price - EGRX

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Eagle Pharmaceuticals Inc EGRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
1.69 3.54% 49.48 48.29 50.35 48.78 47.79 18:31:03
Bid Price Ask Price Spread Spread % News
49.48 74.00 24.52 33.14% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,732 171,055 $ 49.75 $ 8,510,812 155,070 33.80 - 64.94
Last Trade Time Type Quantity Stock Price Currency
16:41:27 1 $ 49.48 USD

Eagle Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 677.14M 13.69M 8.64M $ 195.89M $ 2.53M 1.00 281.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 12.90%

more financials information »

Eagle Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EGRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week51.8752.9447.7250.56185,784-2.39-4.61%
1 Month53.7856.1647.7252.45169,280-4.30-8.0%
3 Months35.8258.1433.8047.39171,61313.6638.14%
6 Months55.6562.4133.8049.98161,529-6.17-11.09%
1 Year54.0664.9433.8053.20149,412-4.58-8.47%
3 Years72.4285.6633.8057.52217,116-22.94-31.68%
5 Years73.11104.1733.0262.94279,296-23.63-32.32%

Eagle Pharmaceuticals Description

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.

Your Recent History
Eagle Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.